PRL has encountered a small number of BA.2 Omicron variants. Our PCR tests remain effective against SARS-CoV-2 and known variants.
Epidemic response laboratory reliable, low-cost, rapid PCR and whole-genome sequencing capabilities are critical for continued vigilance against new SARS-CoV-2 variants. To date, our molecular PCR tests continue to accurately detect SARS-CoV-2 and its known variants, including the “stealth” Omicron subvariant BA.2. As of January 30, our sequencing pipeline has encountered a small number of BA.2 variants, and we continue to report processed genomes to public databases. For more information, visit PRL's Sequencing Tracker and resource links at the bottom of the page.
The experienced service team and strong production support team provide customers with worry-free order services.
简体中文
繁體中文
English
日本語
한국인
通知
